Coronary Artery Disease (CAD)

Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial

- Coronary Artery Disease (CAD) - The Lancet

Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial

- Coronary Artery Disease (CAD) - Journal of the American College of Cardiology (JACC)

Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial

- Coronary Artery Disease (CAD) - JAMA

TRANSFORM I: Knockout of Paclitaxel Over Sirolimus in Drug-Coated Balloons?

- Coronary Artery Disease (CAD) - Journal of the American College of Cardiology (JACC)

Cost-effectiveness of stepwise provisional versus systematic dual stenting strategies in patients with distal bifurcation left main stem lesions: economic analysis of the EBC MAIN trial

- Coronary Artery Disease (CAD) - Open Heart

Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials

- Coronary Artery Disease (CAD) - Circulation

Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years

- Coronary Artery Disease (CAD) - Open Heart

Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial

- Coronary Artery Disease (CAD) - European Journal of Internal Medicine

Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry

- Coronary Artery Disease (CAD) - Minerva Cardiology and Angiology

One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials

- Coronary Artery Disease (CAD) - European Heart Journal